Nevanac

Nevanac

nepafenac

Manufacturer:

Novartis

Distributor:

DKSH
Concise Prescribing Info
Contents
Nepafenac
Indications/Uses
Pain & inflammation associated w/ cataract surgery. Risk reduction of post-op macular oedema associated w/ cataract surgery in diabetic patients.
Dosage/Direction for Use
Instill 1 drop to affected eye(s) tds 1 day prior to cataract surgery, continue on the day of surgery until 1st 2 wk post-op. Risk reduction of post-op macular oedema associated w/ cataract surgery in diabetic patient Instill 1 drop to affected eye(s) tds 1 day prior to surgery, continue on the day of surgery & up to 60 days post-op. Additional drop should be administered 30-120 min prior to surgery.
Contraindications
Hypersensitivity to nepafenac or other NSAIDs.
Special Precautions
Keratitis, epithelial breakdown, corneal thinning, erosion, ulceration or perforation. Patients w/ repeat &/or complex ocular surgeries, corneal denervation & epithelial defects, DM, ocular surface diseases, dry eye or RA; known bleeding tendencies or those receiving drugs known to prolong bleeding time. Increased ocular tissue bleeding in conjuction w/ ocular surgery. Punctuate keratopathy &/or toxic ulcerative keratopathy; acute ocular infection. Prolonged use. Avoid wearing contact lens during treatment. Concomitant use of topical NSAIDs & corticosteroids. Cross sensitivity to acetylsalicylic acid, phenylacetic acid derivatives & other NSAIDs.
Adverse Reactions
Uncommonly, keratitis, punctate keratitis, corneal epithelium defect, eye pain, allergic conjunctivitis, eyelid margin crusting, foreign body sensation in eyes.
ATC Classification
S01BC10 - nepafenac ; Belongs to the class of non-steroidal antiinflammatory agents. Used in the treatment of inflammation of the eye.
Presentation/Packing
Form
Nevanac ophth susp 0.1 %
Packing/Price
5 mL x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in